Bausch Health Companies Inc

General

Total Cases10
Active Cases2
Patents3
TypeOperating Company
Elite Ratings
PTAB
--
--
--

Ratings

Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
10/28/24
STIPULATION AND ORDER dismissing Defendant ALFASIGMA USA, INC. with prejudice. Defendant ALFASIGMA USA, INC. terminated. Signed by Judge Esther Salas on 10/28/2024. (dam) (Entered: 10/28/2024)
10/25/24
Letter from all parties to Judge Salas regarding Stipulation and Order of Dismissal between Plaintiff and Alfasigma USA, Inc.. (Attachments: # [1] Text of Proposed Order)(ABRAHAM, ERIC) (Entered: 10/25/2024)
10/24/24
LETTER ORDER granting extension of time through 11/12/2024 to oppose motion to amend. Signed by Magistrate Judge Jose R. Almonte on 10/24/2024. (lag, ) (Entered: 10/24/2024)
10/24/24
LETTER ORDER granting two-week extension of time to file a joint motion to seal. Signed by Magistrate Judge Jose R. Almonte on 10/24/2024. (lag, ) (Entered: 10/24/2024)
10/23/24
Letter from E. Abraham to Judge Almonte providing the parties' summary of the status of the case in preparation for the October 31 Status Conference re 263 Text Order,,,, Set Hearings,,,. (ABRAHAM, ERIC) (Entered: 10/23/2024)
10/23/24
Letter from K. Butler to Judge Almonte requesting an extension of time re [273] MOTION to Amend/Correct Defendants' Invalidity Contentions. (BUTLER, KRISTINE) (Entered: 10/23/2024)
10/23/24
NOTICE of Appearance by STEPHEN R. DONAT on behalf of ALFASIGMA USA, INC., ALFASIGMA, S.P.A., BAUSCH HEALTH COMPANIES INC, SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. (DONAT, STEPHEN) (Entered: 10/23/2024)
10/23/24
Letter from William P. Deni, Jr. to the Honorable Jose R. Almonte, U.S.M.J. re: extension request. (DENI, WILLIAM) (Entered: 10/23/2024)
10/21/24
Set Deadlines as to [273] MOTION to Amend/Correct Defendants' Invalidity Contentions. Motion set for 11/18/2024 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (adc) (Entered: 10/21/2024)
10/18/24
BRIEF in Support filed by ALFASIGMA USA, INC., ALFASIGMA, S.P.A., BAUSCH HEALTH COMPANIES INC, SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. re [273] MOTION to Amend/Correct Defendants' Invalidity Contentions (Attachments: # [1] Declaration of April E. Weisbruch, # [2] Exhibit A, # [3] Exhibit B, # [4] Exhibit C)(DENI, WILLIAM)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/18/2024)